FAQ

When was PRISM BioLab established?
The Company was established in 2006 with the aim of developing new medicines using small-molecule peptide mimetics. Through more than a decade of research and development, the Company has identified clinical-stage compounds and generated numerous seed compounds. For more information, please visit “About PRISM BioLab.”
On which stock exchange are the Company’s shares listed?
The Company was listed on the Growth Market of the Tokyo Stock Exchange on July 2, 2024.
What is the Company’s securities code?
The Company’s securities code is 206A.
When does the Company announce its financial results?
The Company’s fiscal year ends on September 30, and its annual financial results are announced in November.
Does the Company offer a shareholder benefit program?
The Company does not currently offer a shareholder benefit program.
How many shares are in one trading unit?
One trading unit consists of 100 shares. A trading unit is the minimum number of shares that can ordinarily be traded on the stock exchange.
How can I change my registered name or address?
For procedures relating to the Company’s shares, including changes to your registered name or address, please contact the securities company where your account is held.
Where can I find information on the Company’s past financial performance?
Please refer to the “Financial Results” and “Annual Securities Reports” available in the IR Library.
When is the Annual General Meeting of Shareholders held?
The Annual General Meeting of Shareholders is held within three months after the end of each fiscal year. Details of the date, time, and venue are provided in mid-December to shareholders of record as of September 30 each year.
How can I exercise my voting rights at the General Meeting of Shareholders?
The Company sends a Notice of the General Meeting of Shareholders and a voting rights exercise form to shareholders listed in the shareholder registry as of the record date for the meeting, which is September 30 for the Annual General Meeting of Shareholders. Voting rights may be exercised by:
(1) Attending the meeting and presenting the voting rights exercise form
(2) Indicating your approval or disapproval on the form and returning it by mail
(3) Accessing the designated voting website and submitting your vote online
Who should I contact to request information or materials?
Please contact us here.

All IR Information

>